Dantuma NP - Search Results

1

Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates.

Menéndez-Benito V, Heessen S, Dantuma NP. Menéndez-Benito V, et al. Among authors: dantuma np. Methods Enzymol. 2005;399:490-511. doi: 10.1016/S0076-6879(05)99034-4. Methods Enzymol. 2005. PMID: 16338378

2

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG. Dantuma NP, et al. Nat Biotechnol. 2000 May;18(5):538-43. doi: 10.1038/75406. Nat Biotechnol. 2000. PMID: 10802622

3

Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.

Dantuma NP, Heessen S, Lindsten K, Jellne M, Masucci MG. Dantuma NP, et al. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5. doi: 10.1073/pnas.140217397. Proc Natl Acad Sci U S A. 2000. PMID: 10890896 Free PMC article.

4

Reply to 'Ubiquitin/proteasome system'.

Masucci MG, Dantuma NP. Masucci MG, et al. Among authors: dantuma np. Nat Biotechnol. 2000 Aug;18(8):807. doi: 10.1038/78327. Nat Biotechnol. 2000. PMID: 10932131 No abstract available.

5

Lack of proteasome active site allostery as revealed by subunit-specific inhibitors.

Myung J, Kim KB, Lindsten K, Dantuma NP, Crews CM. Myung J, et al. Among authors: dantuma np. Mol Cell. 2001 Feb;7(2):411-20. doi: 10.1016/s1097-2765(01)00188-5. Mol Cell. 2001. PMID: 11239469

6

Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Lindsten K, Uhlíková T, Konvalinka J, Masucci MG, Dantuma NP. Lindsten K, et al. Among authors: dantuma np. Antimicrob Agents Chemother. 2001 Sep;45(9):2616-22. doi: 10.1128/aac.45.9.2616-2622.2001. Antimicrob Agents Chemother. 2001. PMID: 11502538 Free PMC article.

7

Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Heessen S, Leonchiks A, Issaeva N, Sharipo A, Selivanova G, Masucci MG, Dantuma NP. Heessen S, et al. Among authors: dantuma np. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1532-7. doi: 10.1073/pnas.022306499. Epub 2002 Jan 22. Proc Natl Acad Sci U S A. 2002. PMID: 11805282 Free PMC article.

8

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.

Lindsten K, de Vrij FM, Verhoef LG, Fischer DF, van Leeuwen FW, Hol EM, Masucci MG, Dantuma NP. Lindsten K, et al. Among authors: dantuma np. J Cell Biol. 2002 Apr 29;157(3):417-27. doi: 10.1083/jcb.200111034. Epub 2002 Apr 29. J Cell Biol. 2002. PMID: 11980917 Free PMC article.

9

Avoiding proteasomal processing: the case of EBNA1.

Dantuma NP, Sharipo A, Masucci MG. Dantuma NP, et al. Curr Top Microbiol Immunol. 2002;269:23-36. doi: 10.1007/978-3-642-59421-2_2. Curr Top Microbiol Immunol. 2002. PMID: 12224511 Review.

10

Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system.

Dantuma NP, Masucci MG. Dantuma NP, et al. FEBS Lett. 2002 Oct 2;529(1):22-6. doi: 10.1016/s0014-5793(02)03252-0. FEBS Lett. 2002. PMID: 12354607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results